Compare CADL & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | VINP |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.6M | 638.8M |
| IPO Year | 2021 | 2020 |
| Metric | CADL | VINP |
|---|---|---|
| Price | $10.65 | $9.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $19.00 | $14.00 |
| AVG Volume (30 Days) | ★ 1.1M | 25.3K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $18.07 |
| Revenue Next Year | N/A | $12.74 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $9.29 |
| 52 Week High | $11.36 | $13.61 |
| Indicator | CADL | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 60.63 | 55.60 |
| Support Level | $9.18 | $9.49 |
| Resistance Level | $11.36 | $10.28 |
| Average True Range (ATR) | 0.47 | 0.23 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 87.00 | 74.07 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.